| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |